ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation

Ruth Jessen Hickman, MD  |  Issue: December 2025  |  November 14, 2025

Turmeric

Turmeric, a traditional herb, contains the active ingredient curcumin, which may have anti-inflammatory effects via the nuclear factor kappa B pathway. Some data have shown potential effectiveness in RA, for example, although consumers take the popular supplement for a variety of concerns.12

As a supplement, turmeric is often sold with piperine, the active component of black pepper. Although this might enhance absorption, the science on this isn’t clear. Piperine may cause gastrointestinal upset in some patients, so some may prefer versions without this added ingredient.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Fish Oil

Years of research show that fish oil may help decrease symptoms of such inflammatory diseases as RA, but supplement quality and quantity may be key.13 For example, Dr. Manek has concerns about many common fish oil products with questionable additives. Patients should look at the labels of fish oil available in pharmacies to verify sources of the omega-3 oils.

For patients who want to try it, Dr. Manek recommends a trial of three months, with a dose of at least 2.6 g total of eicosapentaenoic acid and docosahexaenoic acid. Patients should also cut open the capsule and smell to make sure it is not rancid—a very common issue; fish oil can become too oxidized to exert positive health effects.14

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Stress Management

In addition to the key role of sleep, Dr. Manek emphasized the importance of stress management for controlling inflammation. “The medications for inflammatory arthritis and connective tissue diseases do not address the stress pathways that are so fundamental to these conditions,” she said.

The nervous system and immune system are in close communication, in real time, through multiple pathways.15 Comparatively lower vagal tone (e.g., decreased parasympathetic activation) has been found in many immune-mediated inflammatory disorders. This has generated interest in vagal nerve stimulation as a potential anti-inflammatory intervention, with some promising early data.16

Dr. Manek shared results from an interesting exploratory study in RA and psoriatic arthritis that analyzed various parasympathetic and sympathetic measures, including heart rate variability. Patients who responded poorly to anti-tumor necrosis factor therapy initially had lower parasympathetic tone and higher sympathetic activation compared with responders. This underscores a potential role for autonomic effects in inflammatory autoimmune disease.17

A popular breathing technique to increase the parasympathetic tone naturally, according to Dr. Manek, is to breathe in through the nose for four seconds, hold the breath for seven, then exhale through the mouth for eight seconds. It doesn’t take long to share with patients, she said, and they quickly notice a calming effect as the parasympathetic nervous system is stimulated.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAComplementary and Alternative TherapiesDietstress managementsupplements

Related Articles

    Drug Updates

    November 1, 2009

    Information on News Approvals and Medication Safety

    What Diet to Recommend to Patients with Rheumatoid Arthritis?

    November 1, 2013

    With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

    Diet May Help Reduce Inflammation in RA

    March 27, 2023

    In a small study, an anti-inflammatory diet helped reduce pain and swelling in a subset of people with rheumatoid arthritis (RA). Diet changes are complementary to standard treatment. Diet-related research can be challenging, but many patients with RA are motivated to try healthy changes.

    2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response

    March 15, 2016

    SAN FRANCISCO—Inflammation can be either acute or chronic, and it’s the inflammatory responses that don’t shut down normally, or resolve, that cause tissue damage in rheumatic disease. “Resolution bridges the gap between acute inflammation and adaptive immunity,” said Derek W. Gilroy, PhD, head of the Centre for Clinical Pharmacology and Professor of Immunology at University…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences